recently reported two cases of central nervous system (CNS) graft-versus-host disease (GVHD) and performed a literature review. We report a patient with hemiparesis secondary to granulomatous encephalitis that was believed to be a manifestation of GVHD.
The patient is a 41-year-old male diagnosed with follicular lymphoma in 2003. He was initially treated with six cycles of fludarabine, mitoxantrone and rituximab and achieved a partial remission. At relapse in 2004, he received six cycles of CHOP (cyclophosphamide, adriamycin, vincristine and prednisone) with a partial remission. Because of the short duration of initial remission, he was referred for consideration of stem cell transplantation (SCT) and underwent a sibling allogeneic SCT from his HLA-matched sister in 2005. Conditioning chemotherapy was busulfan (1 mg/kg p.o. q.i.d. for 4 days) followed by cyclophosphamide (60 mg/kg i.v. for 2 days) and he received GVHD prophylaxis with short-course methotrexate (days 1, 3, 6 and 11) and cyclosporin.
His post-transplant course was complicated by chronic graft-versus-host disease (cGVHD) of the skin, mouth and eyes, which developed at approximately day þ 120 following transplantation and responded well to treatment with cyclosporin and prednisone. His immunosuppression was then tapered.
In August 2006, at 18 months post transplantation, he developed the sudden onset of weakness and numbness of the left arm, which was progressive. He subsequently developed left-sided facial drooping and numbness. He was admitted to hospital and underwent CT and MRI of the brain, which revealed a large (6.4 Â 5.5 Â 5.6 cm) lesion in the right parietal lobe. The lesion contained multiple round foci measuring up to 1 cm, which enhanced with gadolinium in a homogenous manner. The lesion was associated with a large amount of edema but there was no mass effect ( Figure 1 ). Molecular imaging revealed that the mass was 67 Gallium-avid, but not 201 Thallium-avid. He was extensively investigated for an infectious etiology. Cytomegalovirus viral load was negative. Toxoplasmosis, human immunodeficiency virus (HIV) and syphilis serologies were all negative. Examination of the cerebrospinal fluid (CSF) was negative for toxoplasmosis polymerase-chain reaction and cryptococcus. All bacterial, fungal and viral cultures from the CSF were also negative.
He next underwent a stereotactic-guided needle biopsy. All cultures from that tissue were negative for bacteria, fungi, viruses and mycobacteria. Special stains including Gram's stain, GMS and AFB were negative. Sections of tissue showed multiple fragments of cerebral cortex and gray matter focally infiltrated by a lymphohistiocytic inflammatory cell infiltrate showing prominent perivascular cuffing. Non-caseating granulomas were seen around small vessels, containing lymphocytes, histiocytes, giant cells and rare eosinophils. Although the granulomatous inflammation appeared transmural with reactive endothelial cells, there was no fibrinoid necrosis, endothelial cell destruction or luminal thrombus formation to suggest a diagnosis of vasculitis. Immunohistochemical staining demonstrated that the majority of lymphocytes were CD3 positive suggesting that they were reactive T cells. The final pathologic diagnosis was granulomatous encephalitis (Figure 2) .
The patient was treated with immunosuppression using therapeutic doses of cyclosporin and dexamethasone. There was clinical improvement of his neurologic deficits as well as radiographic improvement on MRI.
Chronic graft-versus-host disease is a significant cause of morbidity and mortality following allogeneic SCT. 2 Although a multisystem syndrome, CNS involvement has rarely been reported and there is no uniform diagnostic approach or diagnostic criteria. Of the previously reported cases, there are limited histological data available and variable pathological findings.
Our case is an important addition to the literature because we have MRI findings that correlate with the clinical presentation as well as histological evidence that supports the diagnosis of GVHD of the CNS. In patients who have had an allogeneic SCT who present with neurological symptoms, and radiographic and histologic findings of an inflammatory process, GVHD should be considered in the differential diagnosis. 
